Peripheral Stent Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 5.50 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Peripheral Stent Market Analysis
The peripheral stent market is expected to grow at a registered CAGR of 5.5% during the forecast period.
During the pandemic, the number of surgical procedures for peripheral arterial disease (PAD) patients got restricted, and the willingness to seek medical treatment also changed. The number of patients with PAD who underwent surgery was significantly reduced, but the severity of their limb ischemia was significantly higher than the previous year, resulting in a higher rate of perioperative complications. According to an article published by PubMed Central in August 2021, during the early pandemic, the reduced number of regular medical follow-ups and hindered hospital access resulted in more acute and advanced clinical presentations of patients with PAD undergoing surgery. Thus, the COVID-19 pandemic significantly impacted the market initially, however, as the pandemic has subsided, cardiological procedures are taking place normally. Hence the studied market is expected to have stable growth during the forecast period of the study.
The peripheral stent market is expected to grow due to the rise in the prevalence of peripheral diseases, the rise in the geriatric population, and the launch of advanced products. For instance, according to the CDC Report in September 2021, PAD affects both men and women, but African Americans are at a higher risk of developing it. When compared to non-Hispanic white people, Hispanics may have similar to slightly higher rates of PAD. PAD affects approximately 6.5 million people in the United States aged 40 and up. Thus, the rising prevalence of PAD is expected to increase the demand for peripheral stents, thereby boosting the market growth.
Additionally, the senior population, which is more prone to developing peripheral vascular diseases, is anticipated to drive the market growth. For instance, as per UN World Population Prospects 2022 data, the share of the global population aged 65 years or above is projected to rise from 10% in 2022 to 16% in 2050. Also it is estimated that by 2050, the number of persons aged 65 years or over worldwide is projected to be more than twice the number of children under age 5 and about the same as the number of children under age 12.
Furthermore, market players use a variety of strategic initiatives to meet their growth goals and expand their market share. Key companies are launching new products, forming partnerships and collaborations, expanding their local and regional footprints, and pursuing mergers and acquisitions. For instance, in March 2022, Cordis, received FDA approval for its Smart Radianz Vascular Stent System, a self-expanding stent designed explicitly for radial peripheral procedures
The market may be in a position to grow, however, the stringent approval process for a stent may restrain it over the forecast period.
Peripheral Stent Market Trends
This section covers the major market trends shaping the Peripheral Stent Market according to our research experts:
The Renal and Related Stents Segment is Expected to Hold Significant Market Share Over the Forecast Period
Renal stents are tubes usually placed in the ureter to prevent blockage and allow urine flow from the kidney to the urinary bladder. The renal and related stent segment is expected to grow over the forecast period due to the prevalence of kidney stones and urinary tract infections (UTIs). For instance, according to the study published in the BMC Urology in October 2021, kidney stones are becoming more common worldwide. In Iran, about 5% of women and 12% of men experience kidney stones at some point.
Additionally, atherosclerosis is a disease that often causes the blockage of renal arteries, leading to renal artery stenting procedures. The increasing prevalence of atherosclerosis is a major factor expected to drive the segment's growth. For instance, according to an article published by JAMA Network in June 2022, a study was conducted in Sweden which showed that the prevalence and burden of atherosclerosis in the general population have been very high, and the estimated prevalence of poly-vascular atherosclerosis ranged from 3% to 42%.
To achieve their growth goals and expand their market share, market players employ a variety of strategic initiatives. New products are being launched, partnerships and collaborations are being formed, local and regional footprints are expanding, and key companies are pursuing mergers and acquisitions. For instance, according to the ClinicalTrials.gov updates on May 2022, a clinical trial is being conducted by Adva-Tec to demonstrate safety and device performance of the ADVA-Tec Uriprene Degradable Temporary Ureteral Stents.
North America is Expected to Hold a Significant Share in the Market Over the Forecast Period
North America is expected to hold a significant market share in the peripheral stent market due to the rising burden of peripheral diseases coupled with the rising geriatric population and the product launches by key market players.
According to the data published by Statistics Canada in July 2022, it is estimated that around 7,330,605 people are aged 65 years or older in Canada, and this accounts for 18.8% of the total population. As the geriatric population is more prone to peripheral diseases, the rising geriatric population is expected to raise the demand for peripheral stents, thereby driving market growth in the region.
According to an article published in Circulation Research in June 2021, peripheral arterial disease is estimated to affect 8.5 million adults in the United States, with a prevalence of 7%. The growing prevalence of PAD diseases in the country has boosted the demand for various treatment options, such as peripheral stents. Thereby, it is anticipated to drive the growth of the peripheral stent market over the forecast period.
Additionally, increasing approvals from the United States FDA and product launches by key players are expected to boost the market. For instance, in August 2021, Vascular Flow Technologies Limited, a designer and developer of implantable medical devices to improve cardiovascular system outcomes, reported that a United States Patent for peripheral stent was issued by the United States Patent and Trademark Office.
Peripheral Stent Industry Overview
The peripheral stent market is fragmented in nature. There is a considerable number of companies significantly contributing to the market growth. Product innovation and ongoing R&D activities to develop advanced technologies have helped boost the market's growth. The competition is fierce due to the fragmented nature of the market. The key players in the stents market are adopting various strategic moves to sustain the intense competition. Some players are Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical, Inc., Cardinal Health, Inc., and iVascular SLU.
Peripheral Stent Market Leaders
-
Medtronic
-
Abbott Laboratories
-
Cook Medical
-
Biotronik
-
Terumo Medical
*Disclaimer: Major Players sorted in no particular order
Peripheral Stent Market News
- In July 2022, BIOTRONIK received United Stated FDA approval for its innovative Pulsar-18 T3 peripheral self-expanding stent system for an improved implantation procedure for endovascular treatments.
- In January 2022, Cook Medical received Breakthrough Device designation from the United States FDA on a new drug-eluting stent below the knee (BTK). This new stent is designed to treat chronic limb-threatening ischemia (CLTI) patients.
Peripheral Stent Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Burden of Cardiac Diseases Couple With the Geriatric Population
- 4.2.2 Technological Advancements in Stent Development
-
4.3 Market Restraints
- 4.3.1 Stringent Approval Process for Stents
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product
- 5.1.1 Bare Metal Stents (BMS)
- 5.1.2 Covered Stents
- 5.1.3 Drug Eluting Stents (DES)
-
5.2 By Artery Type
- 5.2.1 Iliac stents
- 5.2.2 Femoral-popliteal stents
- 5.2.3 Renal & related Artery stents
- 5.2.4 Carotid stents
-
5.3 By End User
- 5.3.1 Hospitals
- 5.3.2 Ambulatory Surgical Centers/Outpatients
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Boston Scientific Inc.
- 6.1.2 Medtronic
- 6.1.3 Terumo Medical
- 6.1.4 Abbott Laboratories
- 6.1.5 Biotronik
- 6.1.6 Lifetech
- 6.1.7 iVascular SLU
- 6.1.8 Stryker
- 6.1.9 Cook Medical
- 6.1.10 Microport Scientific Corporation
- 6.1.11 Stentys S.A.
- 6.1.12 Hellman & Friedman (Cordis Inc.)
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityPeripheral Stent Industry Segmentation
Per the scope of the report, peripheral stents are small tubular metal scaffolds that can be inserted in the peripheral vessels to treat narrowing or blockage within arteries or veins, resulting in improved blood flow. Peripheral stents are often implanted in conjunction with balloon angioplasty.
The Peripheral Stent Market is segmented by Product (Bare Metal Stents (BMS), Covered Stents, Drug-Eluting Stents (DES)), Artery Type (Iliac Stents, Femoral-popliteal Stents, Renal and Related Stents, Carotid Stents), End-User (Hospitals, Ambulatory Surgical, Centers/Outpatientsand), Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (in USD million) for the above segments.
| By Product | Bare Metal Stents (BMS) | |
| Covered Stents | ||
| Drug Eluting Stents (DES) | ||
| By Artery Type | Iliac stents | |
| Femoral-popliteal stents | ||
| Renal & related Artery stents | ||
| Carotid stents | ||
| By End User | Hospitals | |
| Ambulatory Surgical Centers/Outpatients | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Peripheral Stent Market Research FAQs
What is the current Global Peripheral Stent Market size?
The Global Peripheral Stent Market is projected to register a CAGR of 5.5% during the forecast period (2024-2029)
Who are the key players in Global Peripheral Stent Market?
Medtronic , Abbott Laboratories , Cook Medical , Biotronik and Terumo Medical are the major companies operating in the Global Peripheral Stent Market.
Which is the fastest growing region in Global Peripheral Stent Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Peripheral Stent Market?
In 2024, the North America accounts for the largest market share in Global Peripheral Stent Market.
What years does this Global Peripheral Stent Market cover?
The report covers the Global Peripheral Stent Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Peripheral Stent Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Global Peripheral Stent Industry Report
Statistics for the 2024 Global Peripheral Stent market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Peripheral Stent analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
